SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-007653
Filing Date
2021-03-08
Accepted
2021-03-08 16:35:32
Documents
13
Period of Report
2021-03-08
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10021339_8k.htm   iXBRL 8-K 38862
2 EXHIBIT 3.1 brhc10021339_ex3-1.htm EX-3.1 541680
  Complete submission text file 0001140361-21-007653.txt   821583

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA oxfd-20210308.xsd EX-101.SCH 4216
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxfd-20210308_lab.xml EX-101.LAB 23469
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxfd-20210308_pre.xml EX-101.PRE 16744
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10021339_8k_htm.xml XML 4411
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36200 | Film No.: 21722424
SIC: 2835 In Vitro & In Vivo Diagnostic Substances